BliNK Biomedical is a leading U.K. provider of single-use instruments and personalized surgical kits founded in 2014. Demonstrating a commitment to customer service and innovation, their slogan "Blink Medical supplies single-use medical instruments with a focus on customer service and innovation" embodies their mission. The company's rich history as the first supplier of single-use instruments in the country positions them at the forefront of the industry. Blink Medical's collaboration with medical experts across various fields, including ophthalmology, dermatology, cosmetics, and ENT, underscores their dedication to cutting-edge, top-notch single-use instruments and customized surgical packs.
Regarding investments, BliNK Biomedical secured a notable €1.65M Series A investment on 12 July 2016. This investment was led by IDInvest Partners. As the company operates within the Biotechnology and Pharmaceutical industries with its headquarters in France, the recent investment stands as a significant milestone in their growth and market penetration.
No recent news or press coverage available for BliNK Biomedical.